Table 2.
Significant KEGG pathways for G2.
| Pathway | Overlapping genes | p-value | q-value |
|---|---|---|---|
| Cholinergic synapse | CREB3L2; GNG4; CACNA1C; ADCY9; CHRNA7 | 0.002 | 0.015 |
| Hypertrophic cardiomyopathy (HCM) | CACNA1C; ITGB6; ACE; CACNB4 | 0.004 | 0.015 |
| GABAergic synapse | GABRB1; GNG4; CACNA1C; ADCY9 | 0.005 | 0.015 |
| Insulin secretion | CREB3L2; CACNA1C; ADCY9; ADCYAP1 | 0.005 | 0.015 |
| Dilated cardiomyopathy | CACNA1C; ITGB6; ADCY9; CACNB4 | 0.006 | 0.015 |
| Circadian entrainment | GRIN2B; GNG4; CACNA1C; ADCY9 | 0.007 | 0.015 |
| Rap1 signaling pathway | TEK; PDGFD; ADCY9; DOCK4; GRIN2B; SIPA1L1 | 0.007 | 0.015 |
| Adrenergic signaling in cardiomyocytes | CREB3L2; ADRB2; CACNA1C; ADCY9; CACNB4 | 0.008 | 0.015 |
| Retrograde endocannabinoid signaling | GABRB1; GNG4; CACNA1C; ADCY9 | 0.008 | 0.015 |
| Endocytosis | VPS37C; NTRK1; AGAP1; ADRB2; TFRC; HSPA1L | 0.008 | 0.015 |
| Glutamatergic synapse | GRIN2B; GNG4; CACNA1C; ADCY9 | 0.011 | 0.020 |
| Neuroactive ligand–receptor interaction | NTSR2; GRIN2B; ADRB2; CHRNA7; GABRB1; HCRTR2 | 0.014 | 0.023 |
| Dopaminergic synapse | CREB3L2; GRIN2B; GNG4; CACNA1C | 0.019 | 0.027 |
| cAMP signaling pathway | CREB3L2; GRIN2B; ADRB2; CACNA1C; ADCY9 | 0.020 | 0.027 |
| Ras signaling pathway | GRIN2B; GNG4; TEK; PDGFD; RASGRF2 | 0.034 | 0.043 |
KEGG, Kyoto Encyclopedia of Genes and Genomes; GABA, gamma-aminobutyric acid; Rap1, Ras-related protein 1; cAMP, Cyclic adenosine monophosphate.